This article has been updated to include additional background information and Illumina's stock price.
 
NEW YORK (GenomeWeb News) – Illumina said today that it has reorganized its operating structure and divided the firm into two new divisions, the Life Sciences Business Unit and the Diagnostics Business Unit.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.